Stocks · Health care · Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc.

NMRA Clue Score21

United States Fiscal year ends December CIK 0001885522 Results filed 14 Aug 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.09M

$312.14K on a plan · $701.64K straight out of an exercise

Sold at will

$77.47K

3 of 16 sales

Net

−$1.09M

−$77.47K against sales at will